BOGOTA, Colombia – In a move that could lead to sharp increases in the operational timing and costs of introducing generic and subsequent entry of biologic drugs into the Brazilian market, Brazil's National Health Surveillance Agency (Anvisa) updated its guidelines for the issuance of certificates of good practice of bioavailability and bioequivalence studies for both domestic and international labs.
BOGOTA, Colombia – Cuban and Chinese authorities are working together to boost the island´s biotech production through a series of bilateral cooperation agreements that have been in place since 2001.
The surveillance agency of Brazil's Ministry of Health (Anvisa) suspended on Thursday the distribution and commercialization of the meningococcal serogroup C conjugate vaccine Meningitec, following a global recall by its owner Nuron Biotech Inc., of Exton, Pa.
BOGOTA, Colombia – Cuban and Chinese authorities are working together to boost the island´s biotech production through a series of bilateral cooperation agreements that have been in place since 2001.
BOGOTA, Colombia – With the recent announcement of the opening of a new office in Mexico City, Mundipharma International Corp. Ltd. is strengthening its presence in Latin America, a region that the Singapore company considers strategic for its business.
BOGOTA, Colombia – After years of heated debate, Colombian President Juan Manuel Santos and the Ministry of Health signed a decree establishing biotechnology regulations for the country's pharma industry.
